Circulating Tumor DNA in Cerebrospinal Fluid as an Early Biomarker of Leptomeningeal Metastasis (LM)

NCT02071056 · clinicaltrials.gov ↗
COMPLETED
Status
5
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Dartmouth-Hitchcock Medical Center